Imagine watching a favorite movie when suddenly the sound stops. The data representing the audio is missing. All that's left are images. What if artificial intelligence (AI) could analyze each frame ...

Dipa Kamdar does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Inlexzo is supplied as a single-dose intravesical system containing 225mg of gemcitabine plus a sterile urinary catheter and stylet.

Dr. Patrick J. Hensley shares the treatment landscape of non-muscle-invasive bladder, as well as how individual risk factors can alter treatment options. Non-muscle-invasive bladder cancer remains a ...

Frank Garred, 77, completed Inlexzo treatment for recurrent bladder cancer, describing it as manageable with minimal side effects compared with BCG. Frank Garred, a 77-year-old retiree from Denver, ...

KNOXVILLE, Tenn., Sept. 29, 2025 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced the start of a preclinical study of its lead ...

Provectus (PVCT) Biopharmaceuticals announced the start of a preclinical study of its lead investigational drug PV-10 in an orthotopic bladder cancer model. Results are expected in the first quarter ...

On busy days, you may not feel you have the time to sit on a toilet and wait for your bladder to empty, so you “power pee” — you bear down to expel urine faster. “Power peeing is a really common habit ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...